Knight Therapeutics | GUD - Aktuelle Verpflichtungen

Aktienkurs
7.45
Täglich Wechseln
0.01 0.13%
Monatlich
19.58%
Jährlich
22.13%
Q2 Prognose
7.26




Aktuelle Verpflichtungen Veränderung Datum
Acasti Pharma USD 1.24M 1.08M 2025-09
Akebia Therapeutics USD 162.94M 29.56M 2025-12
Alaunos Therapeutics USD 921K 153K 2025-09
Aurora Cannabis CAD 145.94M 21.82M 2025-12
Avita Medical AUD 62.68M 77K 2025-12
Canopy Growth CAD 98.29M 17.19M 2025-12
Cronos Group USD 48.19M 7.12M 2025-12
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
IQVIA Holdings USD 8.34B 170M 2025-12
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Moderna USD 1.99B 306M 2025-12
Omeros USD 85.5M 2.28M 2025-06
Organigram Holdings CAD 94.05M 32.11M 2025-12
Organon & Co USD 2.68B 117M 2025-09
Revvity USD 1.33B 108.5M 2025-12
Tectonic Therapeutic USD 9.67M 293K 2025-12
Tilray USD 259.32M 8.32M 2025-09
Viatris USD 7.09B 269.8M 2025-12
Xeris Pharmaceuticals USD 109.57M 6.63M 2025-12